Cardiology Unit, European Hospital, Rome, Italy.
Department of Internal Medicine, University of Verona, Verona, Italy.
Eat Weight Disord. 2021 Aug;26(6):1697-1707. doi: 10.1007/s40519-020-00982-9. Epub 2020 Aug 26.
There is scientific consensus that obesity increases the risk of cardiovascular diseases (CVD), including heart failure (HF). However, in CVD, many studies observed greater survival in overweight or class 1 obesity individuals. This counterintuitive observation was termed "obesity paradox" (OP).
This article is a narrative overview of the relationship between OP and CVD, particularly HF. The sources used were MEDLINE/PubMed, CINAHL, EMBASE, and Cochrane Library, from 2001 to 31 May 2020, exception for a 1983 work of historical importance. Studies reporting association and prognostic impact of obesity in HF and the impact of body composition on cardiac structure and myocardial function in obesity were also included in this review. In addition, we examined references from the retrieved articles and explored several related websites. Ultimately, we chose 79 relevant documents. Fifty-three were specifically focused on OP and HF.
In this review, we made a summary of the evidence coming from a series of studies investigating OP. Many of these studies do not take into consideration or underestimate some of the more important morpho-functional variables of patients suffering from HF: among these, body composition and visceral adiposity, sarcopenic obesity, muscle fitness (MF), and cardiorespiratory fitness (CRF). A high body mass index (BMI) represents a risk factor for HF, but it also seems to exert a protective effect under certain circumstances. Fat distribution, lean mass, and cardio fitness could play an essential role in determining the observed differences in the HF population.
BMI does not distinguish between the metabolically healthy and metabolically unhealthy obesity. The obesity impact on morbidity and premature mortality can be underestimated and, therefore, may lead to incorrect clinical courses.
Level V, Narrative review.
科学共识认为肥胖会增加心血管疾病(CVD)的风险,包括心力衰竭(HF)。然而,在 CVD 中,许多研究观察到超重或 1 级肥胖个体的生存率更高。这种违反直觉的观察结果被称为“肥胖悖论”(OP)。
本文是对 OP 与 CVD,特别是 HF 之间关系的叙述性综述。使用的来源是 MEDLINE/PubMed、CINAHL、EMBASE 和 Cochrane Library,从 2001 年到 2020 年 5 月 31 日,1983 年的一项具有历史重要性的工作除外。本综述还包括报告肥胖与 HF 之间相关性和预后影响的研究,以及身体成分对肥胖中心脏结构和心肌功能的影响。此外,我们还检查了检索到的文章的参考文献,并探讨了几个相关网站。最终,我们选择了 79 篇相关文献。其中 53 篇专门针对 OP 和 HF。
在本综述中,我们总结了一系列研究 OP 的证据。这些研究中的许多研究没有考虑或低估了患有 HF 的患者的一些更重要的形态功能变量:其中包括身体成分和内脏脂肪、肌少症性肥胖、肌肉健康(MF)和心肺健康(CRF)。高体重指数(BMI)是 HF 的危险因素,但在某些情况下似乎也有保护作用。脂肪分布、瘦体重和心肺健康可能在确定 HF 人群中观察到的差异方面发挥重要作用。
BMI 不能区分代谢健康和代谢不健康的肥胖。肥胖对发病率和过早死亡率的影响可能被低估,因此可能导致不正确的临床过程。
V 级,叙述性综述。